Remidio Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
200
- Latest Deal Type
-
2ndary - Private
- Investors
-
5
Remidio General Information
Description
Developer of ophthalmic imaging devices designed to help diagnose eye diseases in both ophthalmic and nonophthalmic segments. The company's devices facilitate comprehensive eye testing and are integrated with offline, privacy-preserving artificial intelligence algorithms for the detection and monitoring of chronic and acute eye diseases, as well as systemic diseases, and are suitable for use in retail, home, and primary care centers, enabling surgeons to provide painless eye treatment and detect ophthalmic inconsistencies.
Contact Information
Website
www.remidio.comCorporate Office
- Peenya Industrial Area, Phase-I
- Bangalore, Karnataka 560058
- India
Corporate Office
- Peenya Industrial Area, Phase-I
- Bangalore, Karnataka 560058
- India
Remidio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | 01-Feb-2026 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 04-Aug-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 18-Feb-2023 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 26-Nov-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 14-Jan-2016 | Completed | Generating Revenue | |||
| 3. Early Stage VC | Completed | Startup | ||||
| 2. Angel (individual) | $23.3K | $33.5K | Completed | Startup | ||
| 1. Capitalization | 01-Jan-2009 | $10.3K | $10.3K | Completed | Startup |
Remidio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Remidio Patents
Remidio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026215922-A1 | Detecting presence of plus disease within a subject eye | Pending | 08-Apr-2025 | ||
| EP-4763081-A1 | Blood extraction device | Pending | 20-Dec-2024 | ||
| US-20260174364-A1 | Blood extraction device | Pending | 20-Dec-2024 | ||
| WO-2026062706-A1 | Detecting cardiovascular disease based on an eye image of a subject | Pending | 20-Sep-2024 | ||
| WO-2025191613-A1 | Generating a visible light image from a scanning laser ophthalmoscope image | Pending | 13-Mar-2024 | A61B3/0025 |
Remidio Signals
Remidio Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Matter (Consulting Services (B2B)) | Accelerator/Incubator | |||
| VSP Vision | Corporation | |||
| Sun Pharmaceutical Industries | Corporation | Minority | ||
| MedTech Innovator | Accelerator/Incubator | |||
| IKP Knowledge Park | Accelerator/Incubator | Minority |
Remidio Acquisitions (1)
Remidio’s most recent deal was a Merger/Acquisition with Medios Technologies. The deal was made on 01-Jan-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Medios Technologies | 01-Jan-2019 | Merger/Acquisition | Outcome Management (Healthcare) |
Remidio FAQs
-
When was Remidio founded?
Remidio was founded in 2009.
-
Where is Remidio headquartered?
Remidio is headquartered in Bangalore, India.
-
What is the size of Remidio?
Remidio has 200 total employees.
-
What industry is Remidio in?
Remidio’s primary industry is Diagnostic Equipment.
-
Is Remidio a private or public company?
Remidio is a Private company.
-
What is Remidio’s current revenue?
The current revenue for Remidio is .
-
How much funding has Remidio raised over time?
Remidio has raised $1.48M.
-
Who are Remidio’s investors?
Matter (Consulting Services (B2B)), VSP Vision, Sun Pharmaceutical Industries, MedTech Innovator, and IKP Knowledge Park have invested in Remidio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process